UK life sciences partnership to use AI in disease detection

The UK government and the life sciences industry have partnered to develop new technology using artificial intelligence (AI) to detect diseases at an early stage.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

NHS to receive £250m for new AI lab

8 August 2019 The NHS will receive a £250 million investment to develop a new National AI Lab, which will use the technology to improve patient health, the UK government has announced.

Big Pharma

EU invests €35m into AI cancer diagnostics

10 July 2019 The European Commission has pledged €35 million to promote the development of analysis of health images for cancer diagnostics, based on artificial intelligence.

Big Pharma

NHS partners with drugmakers to eliminate hep C

3 May 2019 The National Health Service, the UK’s government-run health system, has partnered with Gilead Sciences, Merck Sharp and Dohme and AbbVie to help eliminate hepatitis C in England.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

UK life sciences partnership to use AI in disease detection

More on this story

Editor's picks

Editor's picks

More features